Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leiomyoma × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms by Site 2 Motor Activity 2 Head and Neck Neoplasms 2 Glioma 2 Carcinoma, Transitional Cell 2 Anxiety Disorders 2 Uterine Neoplasms 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Pain 1

Interventions

telapristone acetate 7 vilaprisan 6 ulipristal acetate 3 Mifepristone 2 Bupivacaine 2 ulipristal 1 ferrous sulfate 1 epigallocatechin gallate 1 Vitamin B 6 1 Uterine Myomectomy 1 Tranexamic Acid 1 Tea 1 Sugars 1 Standard of Care 1 Radiofrequency Ablation 1 Pregabalin 1 Morphine 1 Misoprostol 1 Lidocaine 1 Leuprolide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated

1,272 enrolled 16 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡